BRIEF published on 07/22/2025 at 09:05, 1 year ago Gut Microbiome: A Potential Early Indicator of Dementia Risk Early Detection Screening Tools Gut Microbiome Dementia Risk MCI Prediction
PRESS RELEASE published on 07/22/2025 at 09:00, 1 year ago Study Findings Reveal: Gut Microbiome May Offer Early Insight into Dementia Risk Study reveals gut microbiome may offer early insight into dementia risk, potentially leading to screening tools for routine diagnostics and early interventions. SYNLAB expert co-authors findings Alzheimer's Disease Early Detection SYNLAB Gut Microbiome Dementia Risk
BRIEF published on 07/01/2025 at 09:05, 1 year 1 month ago VαMPiRE Project Makes Strides in Parkinson’s Detection EU Funding Parkinson’s Detection VαMPiRE Project SYNLAB Diagnostics Α-synuclein Biomarkers
PRESS RELEASE published on 07/01/2025 at 09:00, 1 year 1 month ago Milestone Reached in Groundbreaking Project for Early Detection of Parkinson’s Disease SYNLAB reaches a milestone in the VαMPiRE project funded by the EU, focusing on early Parkinson's disease detection with advanced genomics and €8 million funding Parkinson's Disease Diagnostic Test EU Funding SYNLAB VαMPiRE Project
BRIEF published on 10/30/2024 at 07:37, 1 year 9 months ago Cinven Acquires Elliott's Stake in SYNLAB AG with Squeeze-Out Imminent Private Equity Squeeze-out SYNLAB AG Cinven Elliott Advisors
PRESS RELEASE published on 10/30/2024 at 07:32, 1 year 9 months ago Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Cinven acquires Elliott's stake in SYNLAB AG, squeeze-out procedure initiated. SYNLAB's Management Board informed. Ephios Bidco to hold over 96% share capital Private Equity SYNLAB AG Cinven Elliott Squeeze Out
BRIEF published on 09/17/2024 at 16:05, 1 year 10 months ago Cinven to Sell Minority Stake in SYNLAB to Labcorp Investment SYNLAB Cinven Labcorp Minority Stake
PRESS RELEASE published on 09/17/2024 at 16:00, 1 year 10 months ago Cinven to sell minority stake in SYNLAB to strategic investor Labcorp Cinven agrees to sell 15% stake in SYNLAB to Labcorp, a global leader in laboratory services. Transaction aims to enhance lab efficiency and customer experience Strategic Investor Medical Diagnostics SYNLAB Cinven Labcorp
BRIEF published on 06/04/2024 at 20:51, 2 years 2 months ago Cybersecurity Incident at Synnovis in UK Cybersecurity SYNLAB Synnovis NHS England Impact
PRESS RELEASE published on 06/04/2024 at 20:46, 2 years 2 months ago Cybersecurity Incident at Synnovis in UK SYNLAB AG confirms cybersecurity incident at Synnovis in the UK, isolated from previous attacks. Taskforce working to assess impact and minimize disruptions for patients and partners SYNLAB AG Synnovis NHS England Cybersecurity Incident Patient Impact
Published on 08/06/2026 at 03:35, 4 hours 35 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 6 hours 30 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 8 hours 30 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 9 hours ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/05/2026 at 23:01, 9 hours 9 minutes ago Full Circle Lithium Announces Extension of Current Private Placement
Published on 08/06/2026 at 08:05, 5 minutes ago Norlase Expands European Footprint with Direct Commercial Operations in Germany
Published on 08/06/2026 at 08:00, 10 minutes ago 11880 Solutions AG: EBITDA up by 82 per cent in the first half of 2026
Published on 08/06/2026 at 08:00, 10 minutes ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
Published on 08/06/2026 at 08:00, 10 minutes ago Financial results Q2 2026 – Strong first half-year with profitable growth – Guidance confirmed – New partnerships formed
Published on 08/06/2026 at 08:00, 10 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 14 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 14 hours 20 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 14 hours 25 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 14 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
